Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 294
Selected: 0
NCT IDTitle
NCT03850691Radiation and Combination Immunotherapy for Melanoma
NCT03367546Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
NCT00290654Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
NCT00167219Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
NCT00005985Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
NCT00869323Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
NCT05705700Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)
NCT01181258Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
NCT03316456Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction
NCT05700630Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
NCT06594445HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
NCT00167167Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
NCT01009437Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer
NCT06584929Rural Smoking Cessation
NCT07070726UNTOLD Ovarian Cancer Unmet Needs Survey
NCT06030648MT2022-01: MSCs for ALD
NCT02118285Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT04090606Tobacco Constituents and Biomarkers
NCT03579875Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
NCT00963872Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer
NCT00680667Clinical Trial of Trametes Versicolor in Women With Breast Cancer
NCT00855114Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
NCT04228952Metabolism of NNK in Japanese Americans
NCT07591649Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT
NCT04225572Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)
NCT00617929Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
NCT01681875Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes
NCT00609739Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
NCT01560923Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
NCT02999399Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism
NCT03674411Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
NCT03314974Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT00376519Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
NCT04928950Charcoal in Lung Cancer Patients Undergoing TEMLA
NCT04530695Diagnosis and Treatment of Periodontal Disease in Patients With AML
NCT07153016LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT00725062Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
NCT00295880Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
NCT02525029Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
NCT02179359Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
NCT00686556Total Marrow Irradiation for Refractory Acute Leukemia
NCT01505569Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
NCT00373152MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer
NCT00319748Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
NCT00293293Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine
NCT04629209A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
NCT03054909IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer
NCT00365547Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy